Could a simple nutrient shake help preemies breathe easier?

NCT ID NCT07307612

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding DHA/ARA supplements to the milk of extremely premature babies (born at 28 weeks or earlier) during their first two weeks of life can reduce the severity of bronchopulmonary dysplasia, a chronic lung disease. About 150 babies will be randomly assigned to receive either standard fortified human milk or the same milk with extra DHA/ARA. Researchers will then measure breathing support needs at 36 weeks and lung function later on.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
DHA/ARA supplement added to fortified human milk
What this could lead to
If it works, this could lead to a simple nutritional strategy that lowers the risk of chronic lung disease in extremely premature babies.
What could go wrong
This is an early-phase trial with only 150 babies, so results may not be conclusive. The supplement might not improve lung outcomes, and there could be digestive or other side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY DYSPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35233, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.